Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir Valley

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 2, 2013, Pages 297-307

  Wani, H A ^a   Beigh, M A ^b   Amin, S ^b   Bhat, A A ^a   Bhat, S ^c   Khan, H ^a   Naikoo, N A ^a   Farooq, R ^a   Showkat, M ^b   Masood, A ^b   Majid, Sabhiya ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b UNIVERSITY OF KASHMIR   (India)

^c SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

Author keywords

Colorectal cancer; Hypermethylation; p16 gene; Promoter; Tumor suppressor gene

Indexed keywords

BETA ACTIN; GENOMIC DNA; PROTEIN P16;

ARTICLE; CANCER GENETICS; CANCER PROGNOSIS; CANCER STAGING; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; ENDOTHELIUM CELL; EPIGENETICS; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIA; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; WESTERN BLOTTING; CANCER GRADING; COLORECTAL TUMOR; GENETICS; PATHOLOGY; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENES, P16; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC;

EID: 84883466900     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans. World Health Organization 2006.
2. National Cancer Institute. Cancer 2009.
3. Cancer Facts and Figures, American Cancer Society 2008.
4. Shah A, Jan GM. Pattern of cancer at Srinagar (Kashmir). Indian J Pathol Microbiol 1990; 33:118-23.
5. Mir MM, Dar NA, Gochhait S, Zargar SA, Ahangar AG, Bamezai RN. p53 Mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): A high-incidence area. Int J Cancer 2005; 116:62-8. (Pubitemid 40827755)
6. Salam I, Hussain S, Mir MM, et al. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem 2009; 332:51-58.
7. Sameer AS, Chowdhri NA, Siddiqi MA. Adenocarcinoma of the colon and rectum in the Kashmiri population. Indian Journal of Genetics 2009; 15:3.
8. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-32.
9. Fearon ER, Vogelstein BA. Genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.
10. Mustafa A, Ataizi-Celikel C, Duunceli F, Sonmez O, Bahadyr MG, Aydin S. Clinical Significance of p53, K-ras and DCC Gene Alterations in the Stage I-II Colorectal Cancers. J Gastrointestinal Liver Dis 2007;1:11-7. (Pubitemid 46548584)
11. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998; 1378:F115-F177. (Pubitemid 28530512)
12. Rocco JW, Sidransky D. p16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001; 264:42-55.
13. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998; 1378:F115-F177. (Pubitemid 28530512)
14. Wieser RJ, Faust D, Dietrich C, Desch F. p16INK4 mediates contact inhibition of growth. Oncogene 1999; 18:277-281 (Pubitemid 29060603)
15. Awaya H, Takeshima Y, Amatya VJ, Furonaka O, Tagawa K, Kohno N, Inai K. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung. Pathol Int 2004; 54(7):486-9. (Pubitemid 38951664)
16. Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 1997; 18:869-882. (Pubitemid 28132329)
17. Jaenisch R and Bird A. Epigenetic regulation of gene expression: how the genome integrates instrisic and environmental signals. Nat. Genet 2003; 33: 245-54. (Pubitemid 36278835)
18. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor 16/CDKN2/ MTS1 in human cancers. Nat Med 1995; 1:686-92.
19. Yi Jing, Wang ZW, Cang H, Chen YY, Zhao R, Yu BM and Tang XM. p16 gene methylation in colorectal cancers associated with Duke's staging. World J Gastroenterol 2001; 7:5.
20. Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori, Y, Kato H, Watanabe H, Sugimura T. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. Biochem Biophys Res Commun 1994; 203 (2): 1090-5. (Pubitemid 24304941)
21. Hibi K, Nakayama H, Koike M, Kasai Y, Ito Katsuki, Akiyama Seiji, Nakao A. Colorectal Cancers with both p16 and p14 Methylation Show Invasive Characteristics. Cancer Science 2005; 93:883-87. (Pubitemid 35012249)
22. Goto T, Mizukami H, Shirahata A. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Anticancer Res 2008; 29:275-8.
23. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE. P16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443 (7110):53-7.
24. Lam AKY, Ong K, Giv MJ, Ho YH. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 2008; 40:580-5.
25. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y. Colorectal cancer: genetics of development and metastasis. J Gastroenterol 2006; 41:185-92.
26. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR, A novel PCR assay for methylation status of CpG islands. Proc. Natl Acad of Sci USA 1996; 93:9821-6. (Pubitemid 26296693)
27. Guan RJ, Fu YN, Holt PR, Pardee AB. Association of K-ras mutations with P16 methylation in human colon cancer. Gastroenterology 1999; 116:1063-71. (Pubitemid 29203016)
28. Betrand FE, Angus CW, Paartis WJ, Sigounas G. Development pathways in colon cancer: Cross talk between WNT, BMP, Hedgehog and Notch. Cell cycle 2012; 11(23):4344-51.
29. Abbaszadegan MR, Moaven O, Sima HR, et al. p16 promoter hypermethylation: A useful serum marker for early detection of gastric cancer. World J Gastroenterol 2008; 14(13):2055-60. (Pubitemid 351795826)
30. Liang JT, Chang KJ, Chen JC, et al. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with dna replication error and shorter survival. Oncology 1999; 57:149-56.
31. Qing L, Long-bang C, Yong-ming T, Jing W. Promoter hypermethylation of p16 gene and dapk gene in sera from hepatocellular carcinoma (hcc) patients. Chinese J Cancer 2005; 17(4):250-4.
32. Huang Q, Ai L, Zhang ZY, Fan CY, Weiss LM. Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of B-cell primary gastric lymphomas from China. Mod Pathol 2004; 17:416-22. (Pubitemid 41646596)
33. Yu WL, Huang ZH. p16 gene and digestive tract neoplasms. Shijie Huaren Xiaohua Zazhi 1999; 7:1061-2.
34. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042-54. (Pubitemid 37448928)
35. Wiencke JK, Zheng S, Lafuente A. Aberrant methylation of P16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarker Prev 1999; 8:501-6. (Pubitemid 29270333)
36. Perea J, Rueda D. Methylation in colorectal cancer. Rev Esp Enferm Dig 2012; 104(3):107-10.